StonvexLoading…
StonvexStonvexStonvexCore line items from MKTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $846.27M | $817.10M | $752.55M | $718.30M |
Operating Income | $341.84M | $340.87M | $315.02M | $326.88M |
Net Income | $246.63M | $274.18M | $258.06M | $250.22M |
EPS (Diluted) | $6.64 | $7.28 | $6.85 | $6.65 |
Total Assets | $1.93B | $1.79B | $2.02B | $1.61B |
Total Liabilities | $776.63M | $400.56M | $722.10M | $526.68M |
Cash & Equivalents | $519.73M | $544.48M | $451.28M | $430.75M |
Free Cash Flow OCF − CapEx | $373.94M | $375.30M | $324.44M | $276.09M |
Shares Outstanding | 35.78M | 37.65M | 37.90M | 37.65M |